Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/330"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1509"
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:Evidence_assump_list_id	"60"
?:Evidence_enzyme_system	""
?:claim_assumed_valid_for_evidence_application_evidence_1509	?:midazolam_primary_total_clearance_enzyme_cyp3a4
dc:creator	"boycer"
dc:date	"09/21/2009 15:20:18"
?:content	"Drug Interactions .... Midazolam: There were no significant differences in the pharmacokinetics of midazolam, a CYP3A4 and CYP3A5 substrate, in subjects receiving 90 mg cinacalcet once daily for 5 days and a single dose of 2 mg midazolam on day 5 as compared to those of subjects receiving 2 mg midazolam alone. This suggests that cinacalcet would not affect the pharmacokinetics of drugs predominantly metabolized by CYP3A4 and CYP3A5."
rdfs:seeAlso	?:45028573-13c4-4c8b-ae62-6c75bba97c81

The resource appears as object in one triple:

{ cinacalcet_inhibits_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsRefutingEvidence>, evidence_1509 }

Context graph